Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2012
In vitro generation of long-lived human plasma cellsMario Cocco, Sophie Stephenson, Matthew A Care, et al.
British Journal of Haematology|August 26, 2022
Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trialTalha Munir, Jake Emmerson, Anna Hockaday, et al.
Hemasphere|July 22, 2024
Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunitiesKostas Stamatopoulos, Sarka Pavlova, Othman Al-Sawaf, et al.
Molecular Cancer Therapeutics|July 19, 2012
FcRL5 as a target of antibody-drug conjugates for the treatment of multiple myelomaKristi Elkins, Bing Zheng, Maryann Go, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
Blood|April 19, 2013
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLLAnna Vardi, Antonis Dagklis, Lydia Scarfò, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II studyPeter Hillmen, John G Gribben, George A Follows, et al.
Blood|July 28, 2009
Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphomaDavid Dornan, Fiona Bennett, Yvonne Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2022
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular RiskRuth M de Tute, Charlotte Pawlyn, David A Cairns, et al.
Cytometry. Part B, Clinical Cytometry|August 15, 2006
Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization processRemi Letestu, Andy Rawstron, Paolo Ghia, et al.
Pageof 3